Showing results (1281-1290 of 1,411) with videos related to
Sort By:
Pageof 142
Trials|January 21, 2018
Successful recruitment to trials: findings from the SCIMITAR+ TrialEmily Peckham, Catherine Arundel, Della Bailey, et al.Cancer|November 1, 2006
A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumorsDavid P Ryan, Bert H O'Neil, Jeffrey G Supko, et al.Blood|September 27, 2021
Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in miceRachael C Adams, Dylan Carter-Cusack, Samreen N Shaikh, et al.Resuscitation|October 21, 2025
European Resuscitation Council Guidelines 2025 Newborn Resuscitation and Support of Transition of Infants at BirthMarije Hogeveen, Vix Monnelly, Mathijs Binkhorst, et al.Internal Medicine Journal|August 1, 2024
A brief history of rampingBenjamin Cook, James Evenden, Ruby Genborg, et al.American Journal of Surgery|October 5, 2010
The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgeryCoen L Klos, Paul C Shellito, David W Rattner, et al.International Journal of Law and Psychiatry|June 26, 2022
The collaborative development through multidisciplinary and advocate consensus of an accessible notice of rights for people with intellectual disabilities in police custodyGautam Gulati, Alan Cusack, Barry Lynch, et al.BMC Neurology|November 22, 2014
The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageingMeredith A Shafto, Lorraine K Tyler, Marie Dixon, et al.Molecular Autism|June 14, 2025
Access to services for autistic people across EuropeSiti Nurnadhirah Binte Mohd Ikhsan, Rosemary Holt, Joyce Man, et al.EMBO Molecular Medicine|February 3, 2017
Targeting <i>Toxoplasma gondii</i> CPSF3 as a new approach to control toxoplasmosisAndrés Palencia, Alexandre Bougdour, Marie-Pierre Brenier-Pinchart, et al.Pageof 142